COVID-19 updates, including vaccine information, for our patients and visitors Learn More
View All Releases >
UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Instit ...
UC San Diego School of Medicine researchers will receive $6.4 million in National Institutes of Health grant funding to study how external signals and genetic variations influence the behavior of one ...
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-bre ...
UC San Diego Health improved care for more than 32,000 Medicare beneficiaries in San Diego, Riverside, and Imperial Counties, and saved Medicare close to $7 million by utilizing population health tech ...
After experiencing a medical emergency, Don Cohn is giving back to the department that he credits with saving his life.
View All Features >
The team at UC San Diego Health takes a family centered approach to treating children for burns that ensures the social, emotional and psychological needs are met for pediatric patients and their fami ...
María Madrigal, receptora de riñón donante, estaba plagada de bacterias multirresistentes; un tratamiento emergente llamado terapia con bacteriófagos resultó ser el remedio.
Donor kidney recipient Maria Madrigal was plagued by multidrug-resistant bacteria; an emerging treatment called phage therapy proved to be the remedy.
Convalescent therapy is a century-old approach adapted to potentially treating and preventing COVID-19 by boosting patients’ neutralizing antibodies. Edward Cachay, MD, leads a clinical trial at UC Sa ...
In the News
View More >
Authored by Venktesh Ramnath, MD
Features Joseph Gleeson, MD
Features Tarik Benmarhnia, PhD
Features Michael Hsieh, MD
Features Christopher Longhurst, MD, CIO, ACMO